SCHEMBL26633696

SCHEMBL26633696

COc1ccc(CNC(=O)NC2CC3(CC(CN4CCc5ccccc54)C3)C2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 6/20 0.49
▸ SMN1; SMN2 Q16637 5/20 0.49
▸ NPC1 O15118 4/20 0.49
▸ ALDH1A1 P00352 3/20 0.48
▸ GAA P10253 2/20 0.48
▸ MEN1 O00255 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ MCHR1 Q99705 2/20 0.45
▸ HRH3 Q9Y5N1 1/20 0.45
▸ THRB P10828 1/20 0.45
▸ MAPT P10636 4/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ PKM P14618 2/20 0.43
▸ NFKB1 P19838 1/20 0.41
▸ MAOB P27338 1/20 0.41
▸ NFKB2 Q00653 1/20 0.41
▸ RELA Q04206 1/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ CACNA1G O43497 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24011268 0.89 RAB9A (0.56) RAB9ASMN1; SMN2NPC1ALDH1A1GAA
SCHEMBL26633800 0.84 NPC1 (0.54) RAB9ASMN1; SMN2NPC1ALDH1A1MEN1
SCHEMBL30306655 0.84 NPC1 (0.54) RAB9ASMN1; SMN2NPC1ALDH1A1MEN1
SCHEMBL26633743 0.84 RAB9A (0.53) RAB9ASMN1; SMN2NPC1ALDH1A1MEN1
SCHEMBL26764371 0.80 ALDH1A1 (0.54) RAB9ASMN1; SMN2NPC1ALDH1A1GAA
SCHEMBL26633720 0.80 ALDH1A1 (0.54) RAB9ASMN1; SMN2NPC1ALDH1A1GAA
SCHEMBL30288091 0.80 ALDH1A1 (0.54) RAB9ASMN1; SMN2NPC1ALDH1A1GAA
SCHEMBL30288096 0.79 SMN1; SMN2 (0.46) RAB9ASMN1; SMN2NPC1ALDH1A1MEN1
SCHEMBL24011590 0.79 SMN1; SMN2 (0.46) RAB9ASMN1; SMN2NPC1ALDH1A1MEN1
SCHEMBL24011090 0.78 SMN1; SMN2 (0.64) RAB9ASMN1; SMN2NPC1ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115843295-B NAMPT modulators 赛特凯恩蒂克公司 2025-04-15 — — CN disclosed
US-20230348369-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-11-02 — — US disclosed
US-20230348369-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-11-02 — — US disclosed
US-20230348369-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-11-02 — — US disclosed
CN-115843295-A NAMPT modulators 赛特凯恩蒂克公司 2023-03-24 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230348369-A1 NAMPT MODULATORS NAMPT, NNT, NAPRT RAB9A 814/4885SMN1; SMN2 610/4885NPC1 128/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback